Name: Ping An Biomedical Co., Ltd. (PASW) Financial Statements
Creator: FinSpry

Ping An Biomedical Co. Income Statement Analysis

Revenue, earnings, and profit margins in millions CNY

Scale:

Scroll to see more

Ping An Biomedical Co., Ltd. income statement - Annual data in millions CNY
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 2025	Dec 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Revenue & Gross Profit
Revenue	34.15	87.62	82.56	114.55	99.52	55.46
Cost of Revenue	33.20	82.21	78.32	100.40	85.25	44.80
Gross Profit	0.95	5.42	4.24	14.14	14.27	10.67
Operating Expenses
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	6.31	4.85	3.60	3.11	3.37	3.05
Operating Expenses	15.65	5.42	3.63	2.99	5.25	6.21
Operating Income	-14.70	0.00	0.61	11.15	9.02	4.46
Other Income/Expense
Interest Income	0.33	0.00	0.16	0.04	0.00	0.01
Interest Expense	-0.31	0.71	-1.74	1.57	1.36	-1.04
Other Income/Expense	0.00	-0.68	1.01	0.00	0.16	0.00
Income
Income Before Tax	-14.68	-0.68	0.04	9.63	7.82	3.48
Income Tax Expense	-1.86	0.60	1.04	2.40	2.61	1.55
Net Income	-12.83	-1.28	-0.99	7.23	5.21	1.92
Net Income - Continuous Operations	-12.83	-1.28	-0.99	7.23	5.21	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-14.70	0.47	0.65	11.61	9.57	4.46
EBIT	-14.70	0.02	0.61	11.19	9.18	4.46
Depreciation & Amortization	0.01	0.45	0.03	0.41	0.39	0.00
Earnings Per Share
Basic EPS	-1.00	-	-	-	-	-
Diluted EPS	-1.00	-	-	-	-	-
Basic Shares Outstanding	18.48	0.00	18.00	20.50	13.75	18.00
Diluted Shares Outstanding	18.48	0.00	18.00	20.50	13.75	18.00